Phaserx, INC.
SEC CIK 1429386 · PZRX · last insider filing 2017-06-29
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Gillis Steven | Director | filed 2016 - 2017 |
| Griffin Michelle Renee | Director | filed 2016 - 2017 |
| Johnson Paul H | Director | filed 2016 - 2017 |
| Atwood Brian G | Director | filed 2016 - 2017 |
| Phillips Peggy V | Director | filed 2016 - 2017 |
| Schmidt John A Jr | Director | filed 2016 - 2017 |
| Overell Robert W | Director · President and CEO | filed 2016 - 2017 |
| Ulevitch Richard J | Director | filed 2016 - 2016 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Brandt Gordon | Chief Medical Officer | filed 2016 - 2017 |
| Houston Michael | Chief Scientific Officer | filed 2016 - 2017 |
| Tsui Shing-Yin | VP, Finance, Secretary | filed 2016 - 2017 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.